Intrinsiqq
Calcimedica Inc. logo

Calcimedica Inc. Insider Trading

CALC

Compare
Last 12 months

Insiders bought 199K on the open market and sold nothing.

Net open-market
+199K
1 buy · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
1 / 0
executives and directors
Last open-market buy
Jun 2026
Jun 25, 2026

Get an email when CALC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 25
    Fred A Middleton
    Director · bought 248,972 at $0.80
    199K
    10% of stake
  • Sep 18, 2025
    Eric W Roberts
    Chief Business Officer · bought 2,500 at $3.07
    8K
    0.2% of stake
  • Sep 15, 2025
    Eric W Roberts
    Chief Business Officer · bought 3,400 at $2.68
    9K
    0.3% of stake
  • Sep 12, 2025
    Eric W Roberts
    Chief Business Officer · bought 5,000 at $3.12
    16K
    0.5% of stake
  • Sep 9, 2025
    Eric W Roberts
    Chief Business Officer · bought 2,343 at $3.15
    7K
    0.2% of stake
  • Aug 28, 2025 – Aug 29, 2025
    Eric W Roberts
    Chief Business Officer · bought 10,000 at avg $2.85
    29K
    1.0% of stake
  • Aug 21, 2025
    Eric W Roberts
    Chief Business Officer · bought 3,508 at $2.79
    10K
    0.3% of stake
  • Aug 19, 2025 – Aug 20, 2025
    Eric W Roberts
    Chief Business Officer · bought 3,000 at avg $2.74
    8K
    0.3% of stake
  • Aug 19, 2025
    Sudarshan Hebbar
    Chief Medical Officer · bought 9,563 at $2.82
    27K
    18% of stake
  • Aug 15, 2025
    Eric W Roberts
    Chief Business Officer · bought 5,076 at $2.90
    15K
    0.5% of stake
  • Aug 14, 2025 – Aug 15, 2025
    Sudarshan Hebbar
    Chief Medical Officer · bought 5,976 at avg $2.74
    16K
    13% of stake
  • Jul 28, 2025
    Kenneth A. Stauderman
    Chief Scientific Officer · bought 1,000 at $3.96
    4K
    8.4% of stake
  • Jul 25, 2025No plan
    Kenneth A. Stauderman
    Chief Scientific Officer · sold 1,000 at $3.65
    4K
    7.2% of stake
  • Jul 22, 2025
    Eric W Roberts
    Chief Business Officer · bought 1,500 at $3.78
    6K
    0.1% of stake
  • Jul 21, 2025
    Eric W Roberts
    Chief Business Officer · bought 1,500 at $3.37
    5K
    0.1% of stake
  • Jul 21, 2025
    A. Rachel Leheny
    Chief Executive Officer · bought 1,000 at $3.40
    3K
    0.1% of stake
  • Jul 18, 2025
    Robert N Wilson
    Director · bought 4,500 at $2.87
    13K
    1.1% of stake
  • Jul 18, 2025
    Eric W Roberts
    Chief Business Officer · bought 2,000 at $2.88
    6K
    0.2% of stake
  • Jul 14, 2025
    Eric W Roberts
    Chief Business Officer · bought 6,500 at $2.43
    16K
    0.6% of stake
  • Jul 14, 2025
    A. Rachel Leheny
    Chief Executive Officer · bought 2,500 at $2.47
    6K
    0.3% of stake
  • Jul 9, 2025
    Eric W Roberts
    Chief Business Officer · bought 5,000 at $1.60
    8K
    0.5% of stake
  • Jul 1, 2025
    Kenneth A. Stauderman
    Chief Scientific Officer · bought 1,000 at $1.85
    2K
    8.4% of stake
  • Jun 26, 2025
    Eric W Roberts
    Chief Business Officer · bought 4,500 at $1.44
    6K
    0.5% of stake
  • Jun 26, 2025
    Stephen Bardin
    Chief Financial Officer · bought 2,000 at $1.50
    3K
    4.9% of stake
  • Jun 11, 2025
    Eric W Roberts
    Chief Business Officer · bought 5,000 at $1.85
    9K
    0.5% of stake
  • Jun 5, 2025 – Jun 6, 2025
    Eric W Roberts
    Chief Business Officer · bought 10,100 at avg $1.74
    18K
    1.0% of stake
  • May 30, 2025
    Stephen Bardin
    Chief Financial Officer · bought 1,000 at $1.69
    2K
    2.5% of stake
  • Dec 6, 2024
    Fred A Middleton
    Director · bought 4,800 at $2.65
    13K
    0.2% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CALC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CALC

CompareIntrinsic value
GANXGain Therapeutics Inc.
$1.00-4.86%25
KURAKura Oncology Inc.
$6.91-5.99%10
IRDOpus Genetics Inc.
$3.99-2.21%10
PVCTProvectus Biopharmaceuticals, Inc.
$0.05+1.11%6
VSTMVerastem Inc.
$6.33-7.73%40
LXRXLexicon Pharmaceuticals, Inc.
$1.53-8.38%40
COLLCollegium Pharmaceutical Inc.
$24.72-1.94%85
SVRASavara Inc.
$4.26-18.23%10

Spot a number that looks wrong? Check it in CALC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CALC

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.